The Prediction of Type 1 Diabetes Development and Diagnosis of Its Asymptomatic Phase Using Autoantibodies to Human Islets of Langerhans Long Before the Onset of the Disease
Journal Title: Міжнародний ендокринологічний журнал - Year 2016, Vol 7, Issue 79
Abstract
The article deals with an analysis of the latest data of world literature and the results of own twenty-year researches on studying antibodies to human islets of Langerhans, and their use as a test for predicting the risk of type 1 diabetes mellitus (DM), and diagnosis of asymptomatic phase of its development in normoglycemic children of Ukraine. The majority of foreign diabetologists adhere to the same opinion that the determination of islet autoantibodies (IAA) of ICA, IAA, GADA, IA‑2A and ZnT8 in human blood serum has the high diagnostic value and specificity for detecting the autoimmune destructive process in islets, starting with the very early asymptomatic phase of DM development, long before (sometimes months or years before) the manifestation of clinical symptoms of the disease in normoglycemic person. In the simultaneous detection of positivity to the majority of IAA, the development of type 1 DM is inevitable. Our observations, performed for the first time with the participation of children of Ukraine, fully confirm this conclusion. The accuracy of predicting the risk of DM is directly related to the number of different types of IAA, which are used simultaneously, — the more of them, the higher the accuracy of the prediction, and also it is associated with HLA-DR-DQ genotype, the age of the examined person, autoantibodies titer, and the time that has elapsed after the first positive test. With the simultaneous screening of four to five IAA, the accuracy of DM prediction exceeds 90 %. A characteristic feature of IAA is the variability of their titer in the blood, i.e. its increase is alternated with reversion to a normal level. At the same time, IAA are used to detect remaining residual beta cells in the pancreas late after insulin therapy that is necessary for the assignment of more effective immunologic intervention, as well as for more precise differentiation between type 1 and type 2 DM in adults.
Authors and Affiliations
K. P. Zak, V. V. Popova
Study of Pregnancy Course and Outcomes with Analysis of Possible Risk Factors in Patients with Diabetes Mellitus Type 1
There were examined 53 pregnant patients with type 1 diabetes mellitus. When studying the course of pregnancy and its outcomes with analysis of possible risk factors it was established that they are not rare and first of...
Adrenal Incidentaloma: Diagnostics and Choice of Therapeutic Management
Taking into the consideration the widespread usage of modern instrumental methods of topical diagnosis, the choice of the management of patients with adrenal incidentalomas is a topical problem in current medicine. Both...
Diabetes Mellitus Type 2: How to Avoid Errors and to Increase the Effectiveness of Rreatment
The article considers the urgency of the problem of diabetes mellitus incidence (DM) in the world today. It is emphasized that at the present stage of development of diabetology main goal of DM treatment is to achieve bl...
Evaluating the informativity and specificity of diagnostic criteria for primary screening for acromegaly
Background. The most effective method for early diagnosis of any disease, and especially such rare as acromegaly, is considered to be population screening in high-risk groups, the introduction of which in Ukraine require...
Awareness of General Practitioners Regarding Type 2 Diabetes Mellitus Risk Factors
In this article there are presented the results of an anonymous survey of general practitioners regarding their awareness of risk factors in type 2 diabetes mellitus. The data obtained justify the need to give more atten...